Skip to main content

Hearing Loss, Bilateral Sensorineural

0
Pipeline Programs
1
Companies
3
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Cochlear
CochlearAustralia - Macquarie Park
3 programs
CI622DN/A1 trial
Cochlear ImplantN/A1 trial
Cochlear implantN/A1 trial
Active Trials
NCT06424262Active Not Recruiting48Est. May 2026
NCT07139327Active Not Recruiting36Est. Oct 2027
NCT07287124Recruiting56Est. Aug 2028

Trial Timeline

Clinical trial activity over time

2024
2025
2026
2027
2028
CochlearCochlear implant
CochlearCochlear Implant
CochlearCI622D

Clinical Trials (3)

Total enrollment: 140 patients across 3 trials

NCT07287124CochlearCochlear implant

A Pivotal Study to Evaluate the Clinical Benefit, Performance and Safety of a Totally Implantable Cochlear Implant (TICI) System in Adults

Start: Apr 2026Est. completion: Aug 202856 patients
N/ARecruiting
NCT07139327CochlearCochlear Implant

A Pivotal Study to Evaluate the Efficacy and Safety of a Totally Implantable Cochlear Implant (TICI) System in Adults

Start: Dec 2025Est. completion: Oct 202736 patients
N/AActive Not Recruiting

Performance and Hearing-related Outcomes in Adults Implanted With the CI622D Dexamethasone-eluting Cochlear Implant Compared to Those Implanted With a Standard Cochlear Implant (CI622)

Start: Jun 2024Est. completion: May 202648 patients
N/AActive Not Recruiting

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 actively recruiting trials targeting 140 patients
1 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.